公开(公告)号：US09969795B2

公开(公告)日：2018-05-15

申请号：US14956919

申请日：2015-12-02

Applicant: AIMM THERAPEUTICS B.V.

Inventor： Tim Beaumont ,  Mark Jeroen Kwakkenbos ,  Hergen Spits ,  Adrianus Quirinus Bakker ,  Koen Wagner

IPC: C07K16/00 ,  C07K16/10 ,  C07K14/47

CPC classification number: C07K16/1018 ,  C07K14/4703 ,  C07K14/4747 ,  C07K16/00 ,  C07K2317/21 ,  C07K2317/565 ,  C07K2317/92

Abstract: The invention provides means and methods for producing high-affinity antibodies against an antigen of interest, usually stable B-cell cultures.

公开(公告)号：US11136407B2

公开(公告)日：2021-10-05

申请号：US16068742

申请日：2017-01-06

Applicant: AIMM Therapeutics B.V.

Inventor： Hergen Spits ,  Paula Maria Wilhelmina Van Helden ,  Remko Schotte ,  Wouter Pos ,  Christien Fatmawati ,  Danïel Michiel Go ,  Koen Wagner ,  Julien Christian Villaudy

IPC: C07K16/28 ,  G01N33/574 ,  A61P35/00 ,  C07K14/705 ,  A61K39/00

Abstract: The present invention provides novel binding compounds and therapeutic applications thereof.